Loading Events

The Delaware Valley Drug Metabolism: Vendor Show on Wednesday, March 27.

Non-presenting Vendors

  • QPS LLC
  • QRD Pharma
  • BioRepository Resources
  • LabLogic Systems, Inc
  • Discovery Life Sciences / Gentest
  • Eurofins Discovery Services

Schedule

7:30 – 8:30 AM

Registration, networking, visit vendor exhibits, continental breakfast starting at 8:00

8:30 – 8:40 AM

Introduction

8:40 – 9:05 AM

Enhancing Metabolite Identification: Leveraging the Power of Electron-Activated Dissociation (EAD) for Confident Structural Elucidation
David Colquhoun, Ph.D., Market Development Manager, Biomarker Research, SCIEX

9:05 – 9:30 am

Göttingen Minipigs as an Alternative Animal Model to Non-human Primates in Biomedical Research
John Cameron, M.S., Ellegaard BioResearch

9:30 – 9:55 am

Pathways Less Traveled – In Vitro Assays to Investigate Non-CYP Biotransformation Pathways
Tom Fleischmann, Q2 Solutions

9:55 – 10:25 am

Coffee break, networking, visit vendor exhibits

10:25 – 10:50 am

DDI Potential of Major Pharmaceutical Excipients on Transporters and Enzymes
Mark S. Warren, Ph.D., Sr. Study Director & Sr. Principal Investigator, BioIVT

10:50 – 11:15 am

A Workflow for Oligonucleotide Metabolite Identification Studies
Ruisong Pei, Ph.D., Labcorp

11:15 – 11:40 am

Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
Cindy Rewerts, M.S., Sr. Advisor, Aliri

11:40 – 1:00 pm

Lunch, networking, visit vendor exhibits

1:00 – 1:25 pm

Democratizing the Use of Modeling and Simulation with InSilicoTrials’ Biosimulation Platform
Michael Eckstut, Sr. Advisor, InSilicoTrials

1:25 – 1:50 pm

Total Bioanalytical Solutions for Antibody-Drug Conjugates
David A. Johnson, Ph.D., Sr. Director, DMPK, BioAgilytix
Slides available upon request David.Johnson@bioagilytix.com

1:50 – 2:20 pm

Coffee break, networking, visit vendor exhibits

2:20 – 2:50 pm

Advances in High End Mass Spectrometry Solutions to Study Metabolism and Distribution Studies for Drug Discovery and Development
Kieron Faherty Ph.D., Americas Field Marketing Manager, Separations and Mass Spectrometry, Waters Corporation

2:50 – 3:20 pm

Modality specific approaches in in vitro ADME studies
Krisztina Heredi-Szabo, Ph.D., Principal Scientist & Sr. Study Director, Transporter Services, Charles River Labs, Hungary

3:20 – 3:50 pm

Quantitative Whole‑Body Autoradiography (QWBA) in Support of Pre-clinical ADME and Radiation Dosimetry for Clinical hAME Studies
Michael J. Potchoiba, QWBA COE Functional Leader & Study Director, Frontage Laboratories, Inc.

Share This Post, Choose Your Platform!